Discover 3,097 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,097
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
for
Lung Transplant Rejection
Location: Boston MA, The Bronx NY, New York NY, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT06082037
Phase3, Recruiting
A Study of MGC028 in Participants With Advanced Solid Tumors
Location: Boston MA, New York NY, Grand Rapids MI, San Antonio TX,
Sponsor: MacroGenics
Sex: All
Age: 18+
Code: NCT06723236
Phase1, Recruiting
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Boston MA, St Louis MO
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07137416
Phase1, Recruiting
Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location
for
Abortion
Location: Boston MA
Sponsor: Planned Parenthood League of Massachusetts
Sex: Female
Age: 18+
Code: NCT05839899
Phase3, Recruiting
To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
for
Rett Syndrome
Location: Boston MA, The Bronx NY, Baltimore MD, Chicago IL,
Sponsor: Biomed Industries, Inc.
Sex: Female
Age: 5 - 20
Code: NCT06840496
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants
for
Alopecia Areata
Location: Brighton MA, New Haven CT, Washington DC, Cleveland OH,
Sponsor: ASLAN Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05865041
Phase2, Recruiting
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)